2.4. Analysis.

Comparison 2 Conventional doxorubicin versus liposomal‐encapsulated doxorubicin (myocet), Outcome 4 Progression‐free survival.

Comparison 2 Conventional doxorubicin versus liposomal‐encapsulated doxorubicin (myocet), Outcome 4 Progression‐free survival.